FOSTER CITY, CA--(Marketwire - August 07, 2008) - SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the appointment of Jeffery Lange as Vice President, Business Development effective August 11, 2008. In this position, Mr. Lange will leverage his significant biopharmaceutical industry experience to lead business development activities for SciClone’s pipeline of product candidates in viral infectious diseases and oncology as well as its business in China. Mr. Lange will report to Friedhelm Blobel, Ph.D., President and Chief Executive Officer of SciClone.
